IL39110A - Sulphamides,their preparation and pharmaceutical compositions containing them - Google Patents

Sulphamides,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL39110A
IL39110A IL39110A IL3911072A IL39110A IL 39110 A IL39110 A IL 39110A IL 39110 A IL39110 A IL 39110A IL 3911072 A IL3911072 A IL 3911072A IL 39110 A IL39110 A IL 39110A
Authority
IL
Israel
Prior art keywords
sulphamides
preparation
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
IL39110A
Other languages
English (en)
Other versions
IL39110A0 (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IL39110A0 publication Critical patent/IL39110A0/xx
Publication of IL39110A publication Critical patent/IL39110A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL39110A 1971-04-01 1972-03-29 Sulphamides,their preparation and pharmaceutical compositions containing them IL39110A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2115926A DE2115926C3 (de) 1971-04-01 1971-04-01 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel

Publications (2)

Publication Number Publication Date
IL39110A0 IL39110A0 (en) 1972-05-30
IL39110A true IL39110A (en) 1975-02-10

Family

ID=5803592

Family Applications (1)

Application Number Title Priority Date Filing Date
IL39110A IL39110A (en) 1971-04-01 1972-03-29 Sulphamides,their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US4038314A (fr)
JP (3) JPS5735193B1 (fr)
AR (6) AR204905A1 (fr)
AT (7) AT327173B (fr)
AU (1) AU470838B2 (fr)
BE (1) BE781542A (fr)
CH (6) CH590219A5 (fr)
DE (1) DE2115926C3 (fr)
DK (1) DK140836B (fr)
ES (4) ES401332A1 (fr)
FI (1) FI58325C (fr)
FR (1) FR2132372B1 (fr)
GB (1) GB1381184A (fr)
IE (1) IE36240B1 (fr)
IL (1) IL39110A (fr)
NL (1) NL170850C (fr)
NO (1) NO135247C (fr)
PH (1) PH14121A (fr)
SE (1) SE393106B (fr)
ZA (1) ZA722177B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435721A (en) * 1972-05-18 1976-05-12 Lilly Industries Ltd Benzoxazole derivatives
CA1147342A (fr) * 1977-10-12 1983-05-31 Kazuo Imai Procede de preparation de nouveaux derives de la phenylethanolamine
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US4558156A (en) * 1980-02-08 1985-12-10 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl-substituted phenethylamine derivatives
DE3220598A1 (de) * 1982-06-01 1983-12-01 Boehringer Ingelheim KG, 6507 Ingelheim Lipolytische zusammensetzungen und mittel zur behandlung der fettsucht
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions
GB8502892D0 (en) * 1985-02-05 1985-03-06 Sterwin Ag Aerosol composition
NZ226934A (en) * 1987-11-13 1991-01-29 Glaxo Group Ltd Phenethanolamine derivatives and pharmaceutical compositions
US20040127733A1 (en) 2002-10-31 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, processes for preparing them and their use as pharmaceutical compositions
DE10251170A1 (de) * 2002-10-31 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004021779A1 (de) 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052127A1 (de) 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7718822B2 (en) * 2007-08-28 2010-05-18 Sepracor Inc. Carbamate Stereoisomer
CN109535007A (zh) * 2018-11-07 2019-03-29 万华化学集团股份有限公司 一种二氨基二环己基甲烷同分异构体分离方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3804834A (en) * 1967-10-16 1974-04-16 Boehringer Sohn Ingelheim 1-(2',3',4'-trisubstituted-phenyl)-2-amino-alkanols-(1)and salts thereof
US3701808A (en) * 1967-12-21 1972-10-31 Allen & Hanburys Ltd Phenylethanolamines
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US3711545A (en) * 1971-02-23 1973-01-16 Smith Kline French Lab Alpha-aminoalkyl-4-hydroxy-3-sulfamoylaminobenzyl alcohols
BE794414A (fr) * 1972-01-25 1973-07-23 Sandoz Sa Nouveaux amino-alcools, leur preparation et leur application comme medicament

Also Published As

Publication number Publication date
NL170850B (nl) 1982-08-02
JPS5718660A (en) 1982-01-30
ZA722177B (en) 1973-12-19
IE36240L (en) 1972-10-01
AT321888B (de) 1975-04-25
JPS5929190B2 (ja) 1984-07-18
AT320613B (de) 1975-02-25
JPS5718662A (en) 1982-01-30
CH580068A5 (fr) 1976-09-30
AR209268A1 (es) 1977-04-15
ATA915074A (de) 1975-04-15
FR2132372B1 (fr) 1975-06-20
CH587236A5 (fr) 1977-04-29
CH590219A5 (fr) 1977-07-29
AT326628B (de) 1975-12-29
AR200002A1 (es) 1974-10-15
AR199809A1 (es) 1974-09-30
IE36240B1 (en) 1976-09-15
AT327173B (de) 1976-01-26
FI58325C (fi) 1981-01-12
BE781542A (fr) 1972-10-02
DE2115926B2 (de) 1977-09-15
ES419936A1 (es) 1976-05-01
AT327174B (de) 1976-01-26
PH14121A (en) 1981-02-26
AU4059272A (en) 1973-10-04
NO135247B (fr) 1976-11-29
GB1381184A (en) 1975-01-22
NL7204316A (fr) 1972-10-03
DK140836C (fr) 1980-04-21
DK140836B (da) 1979-11-26
AR200116A1 (es) 1974-10-24
CH572905A5 (en) 1976-02-27
ES419935A1 (es) 1976-05-01
CH580069A5 (fr) 1976-09-30
ES401332A1 (es) 1975-02-16
AT321889B (de) 1975-04-25
DE2115926C3 (de) 1978-05-03
JPS5929191B2 (ja) 1984-07-18
NL170850C (nl) 1983-01-03
JPS5735193B1 (fr) 1982-07-27
ATA284472A (de) 1975-03-15
FR2132372A1 (fr) 1972-11-17
ES419934A1 (es) 1976-05-01
SE393106B (sv) 1977-05-02
AR204905A1 (es) 1976-03-19
CH587237A5 (fr) 1977-04-29
FI58325B (fi) 1980-09-30
AU470838B2 (en) 1973-10-04
IL39110A0 (en) 1972-05-30
US4038314A (en) 1977-07-26
AR210055A1 (es) 1977-06-30
NO135247C (fr) 1977-03-09
DE2115926A1 (de) 1972-10-12
ATA915174A (de) 1975-04-15

Similar Documents

Publication Publication Date Title
IL38687A (en) Omega-imidazolyl-omega-phenoxy-alkanones,their preparation and pharmaceutical compositions containing them
IL42430A0 (en) Pyridopyrrolobenzheterocycles,their preparation and pharmaceutical compositions containing them
IL39110A (en) Sulphamides,their preparation and pharmaceutical compositions containing them
IL40184A0 (en) 5-cinnamoyl-benzofurans,their preparation and pharmaceutical compositions containing them
IL43001A0 (en) Novel 4-biphenylyl-alcohols,their preparation and pharmaceutical compositions containing them
IL37598A0 (en) Bis-chromonyloxy compounds,their preparation and pharmaceutical compositions containing them
IL42429A0 (en) 2-alkoxycephalosporins,their preparation and pharmaceutical compositions containing them
IL40412A0 (en) Substituted 3-hydroxymethyl-isoquinolines and salts thereof,their preparation and pharmaceutical compositions containing them
IL49286A0 (en) Novel 1-iodo-1-trans-alkenes,their preparation and pharmaceutical compositions containing them
IL40572A0 (en) Biphenylyl-butanols,their preparation and pharmaceutical compositions containing them
IL48790A0 (en) Novel hydroxy-pyrimidines,their preparation and pharmaceutical compositions containing them
IL36743A (en) Phenylaminoalkanes,their preparation and pharmaceutical compositions containing them
IL38593A0 (en) Substituted 2-arylamino-imidazoline-(2)derivatives,their preparation and pharmaceutical compositions containing them
IL37588A0 (en) Pyrimidoisoquinolines,their preparation and pharmaceutical compositions containing them
IL42790A0 (en) 4a-aryl-trans-decahydroisoquino-lines,their preparation and pharmaceutical compositions containing them
IL42613A0 (en) Amino-imidazo-and amino-pyrazolo-isoquinolines,their preparation and pharmaceutical compositions containing them
IL41200A0 (en) Substituted 3-amino-prop-1-enes,their preparation and pharmaceutical compositions containing them
IL40362A0 (en) Novel 4-oxo-4h-1-benzopyran and-thiabenzopyran derivatives,their preparation and pharmaceutical compositions containing them
IL41034A0 (en) Novel 6-aza-3h-1,4-benzodiazepines their preparation and pharmaceutical compositions containing them
IL40828A0 (en) Dibenzothiepin derivatives,their manufacture and pharmaceutical compositions containing them
IL40747A0 (en) 1-phenyl-3-hydroxy-3-methyl-triazenes,their preparation and pharmaceutical compositions containing them
IL39620A0 (en) Substituted phenylimidazolidinones and their salts,their preparation and pharmaceutical compositions containing them
IL39355A0 (en) Androstan-17beta-yl-acrylonitrile derivatives,their preparation and pharmaceutical compositions containing them
IL40328A0 (en) Novel cardiac glycosides,their preparation and pharmaceutical compositions containing them
IL39381A0 (en) Rheadan-type alkaloids,their preparation and pharmaceutical compositions containing them